Loading…
Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea Pigs
The therapeutic effects of topically applied foscarnet sodium and acyclovir on cutaneous infections due to herpes simplexvirus type 1(HSV-1) were studied in guinea pigs. Foscarnet cream (3%) reduced both the cumulative vesicle score and the time for healing when HSV-1 strains C42 and 79 were tested....
Saved in:
Published in: | The Journal of infectious diseases 1982-04, Vol.145 (4), p.569-573 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c385t-944a98fa05325128bbf9729ff2b76caf12e268c649fae1bb3f47b98e2dde7e343 |
---|---|
cites | |
container_end_page | 573 |
container_issue | 4 |
container_start_page | 569 |
container_title | The Journal of infectious diseases |
container_volume | 145 |
creator | Alenius, S. Berg, M. Broberg, F. Eklind, K. Lindborg, B. Öberg, B. |
description | The therapeutic effects of topically applied foscarnet sodium and acyclovir on cutaneous infections due to herpes simplexvirus type 1(HSV-1) were studied in guinea pigs. Foscarnet cream (3%) reduced both the cumulative vesicle score and the time for healing when HSV-1 strains C42 and 79 were tested. The application of foscarnet in cream form resulted in a dose-dependent reduction in skin virus titers and vesicle scores at concentrations ranging from 0.05% to 3%. Infections due to HSV-1 strain 79, but not those due to strain C42, were sensitive to treatment with 5% acyclovir in polyethylene glycolointment. Topical application of 3% acyclovirin dimethyl sulfoxide on infections due to HSV-1 strain C42 resulted in a reduction in the skin virus titers, lesion scores, and the time for healing. Acyclovir, in both polyethylene glycoland dimethyl sulfoxide, was consistently less active than foscarnet cream in these animal experiments. |
doi_str_mv | 10.1093/infdis/145.4.569 |
format | article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_74015345</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30109526</jstor_id><sourcerecordid>30109526</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-944a98fa05325128bbf9729ff2b76caf12e268c649fae1bb3f47b98e2dde7e343</originalsourceid><addsrcrecordid>eNqFkc1v0zAYxi0EGqVw54LkE7d0_ozj41TWddMQHy0IcbGc5DV4JHGwE7Se-NeXKVU5cvLh9zyP5PeH0GtKVpRofu47V_t0ToVciZXM9RO0oJKrLM8pf4oWhDCW0ULr5-hFSneEEMFzdYbOcqa04sUC_d3_hGh7GAdf4UvnoBoSDg5vQqps7GDAu1D7scW2q_FFdaia8MdHHDq8HgfbQRgTvu4eaz50Cb8bAQ8BbyH2kPDOt30D9_irj1Nsf-gBU-w7fDX6Diz-6H-kl-iZs02CV8d3ib5sLvfrbXb74ep6fXGbVbyQQ6aFsLpwlkjOJGVFWTqtmHaOlSqvrKMMWF5UudDOAi1L7oQqdQGsrkEBF3yJ3s67fQy_R0iDaX2qoGnmPxglyHQ4If8bpFIyWky3XyIyB6sYUorgTB99a-PBUGIe5ZhZjpnkGGEmOVPlzXF7LFuoT4WjjX_8Lg0hnjAn05xk-cSzmfs0wP2J2_jL5Iorabbfvpub95928rPcGMEfAPHspec</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15521809</pqid></control><display><type>article</type><title>Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea Pigs</title><source>JSTOR Archival Journals and Primary Sources Collection</source><source>Oxford University Press Archive</source><creator>Alenius, S. ; Berg, M. ; Broberg, F. ; Eklind, K. ; Lindborg, B. ; Öberg, B.</creator><creatorcontrib>Alenius, S. ; Berg, M. ; Broberg, F. ; Eklind, K. ; Lindborg, B. ; Öberg, B.</creatorcontrib><description>The therapeutic effects of topically applied foscarnet sodium and acyclovir on cutaneous infections due to herpes simplexvirus type 1(HSV-1) were studied in guinea pigs. Foscarnet cream (3%) reduced both the cumulative vesicle score and the time for healing when HSV-1 strains C42 and 79 were tested. The application of foscarnet in cream form resulted in a dose-dependent reduction in skin virus titers and vesicle scores at concentrations ranging from 0.05% to 3%. Infections due to HSV-1 strain 79, but not those due to strain C42, were sensitive to treatment with 5% acyclovir in polyethylene glycolointment. Topical application of 3% acyclovirin dimethyl sulfoxide on infections due to HSV-1 strain C42 resulted in a reduction in the skin virus titers, lesion scores, and the time for healing. Acyclovir, in both polyethylene glycoland dimethyl sulfoxide, was consistently less active than foscarnet cream in these animal experiments.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/145.4.569</identifier><identifier>PMID: 6279738</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Acyclovir ; Administration, Topical ; Animals ; Cream ; Dose-Response Relationship, Drug ; Foscarnet ; Glycols ; Guanine - administration & dosage ; Guanine - analogs & derivatives ; Guanine - therapeutic use ; Guinea Pigs ; Herpes Simplex - drug therapy ; herpes simplex virus 1 ; Human herpesvirus 1 ; Infections ; Lesions ; Medical treatment ; Ointments ; Organophosphorus Compounds - therapeutic use ; Phosphonoacetic Acid - administration & dosage ; Phosphonoacetic Acid - analogs & derivatives ; Phosphonoacetic Acid - therapeutic use ; Polyethylenes ; Simplexvirus - growth & development ; Skin Diseases - drug therapy ; Sodium ; Therapeutics ; Viruses</subject><ispartof>The Journal of infectious diseases, 1982-04, Vol.145 (4), p.569-573</ispartof><rights>Copyright 1982 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-944a98fa05325128bbf9729ff2b76caf12e268c649fae1bb3f47b98e2dde7e343</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30109526$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30109526$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,58238,58471</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6279738$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alenius, S.</creatorcontrib><creatorcontrib>Berg, M.</creatorcontrib><creatorcontrib>Broberg, F.</creatorcontrib><creatorcontrib>Eklind, K.</creatorcontrib><creatorcontrib>Lindborg, B.</creatorcontrib><creatorcontrib>Öberg, B.</creatorcontrib><title>Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea Pigs</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>The therapeutic effects of topically applied foscarnet sodium and acyclovir on cutaneous infections due to herpes simplexvirus type 1(HSV-1) were studied in guinea pigs. Foscarnet cream (3%) reduced both the cumulative vesicle score and the time for healing when HSV-1 strains C42 and 79 were tested. The application of foscarnet in cream form resulted in a dose-dependent reduction in skin virus titers and vesicle scores at concentrations ranging from 0.05% to 3%. Infections due to HSV-1 strain 79, but not those due to strain C42, were sensitive to treatment with 5% acyclovir in polyethylene glycolointment. Topical application of 3% acyclovirin dimethyl sulfoxide on infections due to HSV-1 strain C42 resulted in a reduction in the skin virus titers, lesion scores, and the time for healing. Acyclovir, in both polyethylene glycoland dimethyl sulfoxide, was consistently less active than foscarnet cream in these animal experiments.</description><subject>Acyclovir</subject><subject>Administration, Topical</subject><subject>Animals</subject><subject>Cream</subject><subject>Dose-Response Relationship, Drug</subject><subject>Foscarnet</subject><subject>Glycols</subject><subject>Guanine - administration & dosage</subject><subject>Guanine - analogs & derivatives</subject><subject>Guanine - therapeutic use</subject><subject>Guinea Pigs</subject><subject>Herpes Simplex - drug therapy</subject><subject>herpes simplex virus 1</subject><subject>Human herpesvirus 1</subject><subject>Infections</subject><subject>Lesions</subject><subject>Medical treatment</subject><subject>Ointments</subject><subject>Organophosphorus Compounds - therapeutic use</subject><subject>Phosphonoacetic Acid - administration & dosage</subject><subject>Phosphonoacetic Acid - analogs & derivatives</subject><subject>Phosphonoacetic Acid - therapeutic use</subject><subject>Polyethylenes</subject><subject>Simplexvirus - growth & development</subject><subject>Skin Diseases - drug therapy</subject><subject>Sodium</subject><subject>Therapeutics</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><recordid>eNqFkc1v0zAYxi0EGqVw54LkE7d0_ozj41TWddMQHy0IcbGc5DV4JHGwE7Se-NeXKVU5cvLh9zyP5PeH0GtKVpRofu47V_t0ToVciZXM9RO0oJKrLM8pf4oWhDCW0ULr5-hFSneEEMFzdYbOcqa04sUC_d3_hGh7GAdf4UvnoBoSDg5vQqps7GDAu1D7scW2q_FFdaia8MdHHDq8HgfbQRgTvu4eaz50Cb8bAQ8BbyH2kPDOt30D9_irj1Nsf-gBU-w7fDX6Diz-6H-kl-iZs02CV8d3ib5sLvfrbXb74ep6fXGbVbyQQ6aFsLpwlkjOJGVFWTqtmHaOlSqvrKMMWF5UudDOAi1L7oQqdQGsrkEBF3yJ3s67fQy_R0iDaX2qoGnmPxglyHQ4If8bpFIyWky3XyIyB6sYUorgTB99a-PBUGIe5ZhZjpnkGGEmOVPlzXF7LFuoT4WjjX_8Lg0hnjAn05xk-cSzmfs0wP2J2_jL5Iorabbfvpub95928rPcGMEfAPHspec</recordid><startdate>198204</startdate><enddate>198204</enddate><creator>Alenius, S.</creator><creator>Berg, M.</creator><creator>Broberg, F.</creator><creator>Eklind, K.</creator><creator>Lindborg, B.</creator><creator>Öberg, B.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>198204</creationdate><title>Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea Pigs</title><author>Alenius, S. ; Berg, M. ; Broberg, F. ; Eklind, K. ; Lindborg, B. ; Öberg, B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-944a98fa05325128bbf9729ff2b76caf12e268c649fae1bb3f47b98e2dde7e343</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Acyclovir</topic><topic>Administration, Topical</topic><topic>Animals</topic><topic>Cream</topic><topic>Dose-Response Relationship, Drug</topic><topic>Foscarnet</topic><topic>Glycols</topic><topic>Guanine - administration & dosage</topic><topic>Guanine - analogs & derivatives</topic><topic>Guanine - therapeutic use</topic><topic>Guinea Pigs</topic><topic>Herpes Simplex - drug therapy</topic><topic>herpes simplex virus 1</topic><topic>Human herpesvirus 1</topic><topic>Infections</topic><topic>Lesions</topic><topic>Medical treatment</topic><topic>Ointments</topic><topic>Organophosphorus Compounds - therapeutic use</topic><topic>Phosphonoacetic Acid - administration & dosage</topic><topic>Phosphonoacetic Acid - analogs & derivatives</topic><topic>Phosphonoacetic Acid - therapeutic use</topic><topic>Polyethylenes</topic><topic>Simplexvirus - growth & development</topic><topic>Skin Diseases - drug therapy</topic><topic>Sodium</topic><topic>Therapeutics</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alenius, S.</creatorcontrib><creatorcontrib>Berg, M.</creatorcontrib><creatorcontrib>Broberg, F.</creatorcontrib><creatorcontrib>Eklind, K.</creatorcontrib><creatorcontrib>Lindborg, B.</creatorcontrib><creatorcontrib>Öberg, B.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alenius, S.</au><au>Berg, M.</au><au>Broberg, F.</au><au>Eklind, K.</au><au>Lindborg, B.</au><au>Öberg, B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea Pigs</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1982-04</date><risdate>1982</risdate><volume>145</volume><issue>4</issue><spage>569</spage><epage>573</epage><pages>569-573</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>The therapeutic effects of topically applied foscarnet sodium and acyclovir on cutaneous infections due to herpes simplexvirus type 1(HSV-1) were studied in guinea pigs. Foscarnet cream (3%) reduced both the cumulative vesicle score and the time for healing when HSV-1 strains C42 and 79 were tested. The application of foscarnet in cream form resulted in a dose-dependent reduction in skin virus titers and vesicle scores at concentrations ranging from 0.05% to 3%. Infections due to HSV-1 strain 79, but not those due to strain C42, were sensitive to treatment with 5% acyclovir in polyethylene glycolointment. Topical application of 3% acyclovirin dimethyl sulfoxide on infections due to HSV-1 strain C42 resulted in a reduction in the skin virus titers, lesion scores, and the time for healing. Acyclovir, in both polyethylene glycoland dimethyl sulfoxide, was consistently less active than foscarnet cream in these animal experiments.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>6279738</pmid><doi>10.1093/infdis/145.4.569</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1899 |
ispartof | The Journal of infectious diseases, 1982-04, Vol.145 (4), p.569-573 |
issn | 0022-1899 1537-6613 |
language | eng |
recordid | cdi_proquest_miscellaneous_74015345 |
source | JSTOR Archival Journals and Primary Sources Collection; Oxford University Press Archive |
subjects | Acyclovir Administration, Topical Animals Cream Dose-Response Relationship, Drug Foscarnet Glycols Guanine - administration & dosage Guanine - analogs & derivatives Guanine - therapeutic use Guinea Pigs Herpes Simplex - drug therapy herpes simplex virus 1 Human herpesvirus 1 Infections Lesions Medical treatment Ointments Organophosphorus Compounds - therapeutic use Phosphonoacetic Acid - administration & dosage Phosphonoacetic Acid - analogs & derivatives Phosphonoacetic Acid - therapeutic use Polyethylenes Simplexvirus - growth & development Skin Diseases - drug therapy Sodium Therapeutics Viruses |
title | Therapeutic Effects of Foscarnet Sodium and Acyclovir on Cutaneous Infections Due to Herpes Simplex Virus Type 1 in Guinea Pigs |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T23%3A48%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20Effects%20of%20Foscarnet%20Sodium%20and%20Acyclovir%20on%20Cutaneous%20Infections%20Due%20to%20Herpes%20Simplex%20Virus%20Type%201%20in%20Guinea%20Pigs&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Alenius,%20S.&rft.date=1982-04&rft.volume=145&rft.issue=4&rft.spage=569&rft.epage=573&rft.pages=569-573&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/145.4.569&rft_dat=%3Cjstor_proqu%3E30109526%3C/jstor_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c385t-944a98fa05325128bbf9729ff2b76caf12e268c649fae1bb3f47b98e2dde7e343%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=15521809&rft_id=info:pmid/6279738&rft_jstor_id=30109526&rfr_iscdi=true |